[{"title": "Tela Bio reiterates $85M-$88M 2025 revenue target as international expansion accelerates", "url": "https://www.msn.com/en-us/money/companies/tela-bio-reiterates-85m-88m-2025-revenue-target-as-international-expansion-accelerates/ar-AA1KkVGD", "snippet": "TELA Bio reports record Q2 2025 revenue, driven by global sales growth, innovative product launches, and a patient-focused commercial strategy.", "published": "2025-08-11T23:06:19+00:00"}, {"title": "TELA Bio Reports Strong Q2 2025 Financial Results", "url": "https://www.msn.com/en-us/money/top-stocks/tela-bio-reports-strong-q2-2025-financial-results/ar-AA1KlaUX", "snippet": "TELA Bio ( ($TELA) ) has provided an announcement. On August 11, 2025, TELA Bio reported its financial results for the second quarter of 2025,", "published": "2025-08-11T20:37:22+00:00"}, {"title": "TELA Bio, Inc. (TELA) Reports Q2 Loss, Lags Revenue Estimates", "url": "https://www.msn.com/en-us/money/taxes/tela-bio-inc-tela-reports-q2-loss-lags-revenue-estimates/ar-AA1Kl3Nl", "snippet": "TELA Bio, Inc. (TELA) came out with a quarterly loss of $0.22 per share versus the Zacks Consensus Estimate of a loss of $0.18. This compares to a loss of $0.51 per share a year ago. These figures are adjusted for non-recurring items.", "published": "2025-08-11T23:00:09+00:00"}, {"title": "TELA Bio Inc (TELA) Q2 2025 Earnings Call Highlights: Record Revenue and Strategic Growth ...", "url": "https://finance.yahoo.com/news/tela-bio-inc-tela-q2-070601302.html", "snippet": "Grew 12% year over year. OviTex PRS Revenue Growth: Increased 53% year over year. OviTex Unit Sales Growth: Grew 17% for the quarter. PRS Unit Sales Growth: Increased 40% for the quarter. Gross Margin: 69.", "published": "2025-08-12T07:35:00+00:00"}]